[1]黄晓凤 熊峰.超声心动图技术在优化心脏再同步化治疗效果中的应用[J].心血管病学进展,2019,(7):1043-1046.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.020]
 HUANG XiaofengXIONG Feng.Application of Echocardiography in Optimizing Cardiac Resynchronization Therapy[J].Advances in Cardiovascular Diseases,2019,(7):1043-1046.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.020]
点击复制

超声心动图技术在优化心脏再同步化治疗效果中的应用()
分享到:

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2019年7期
页码:
1043-1046
栏目:
综述
出版日期:
2019-10-25

文章信息/Info

Title:
Application of Echocardiography in Optimizing Cardiac Resynchronization Therapy
作者:
黄晓凤 熊峰
黄晓凤 熊峰 (西南交通大学附属医院 成都市第三人民医院心研所,四川 成都 610036 )
Author(s):
HUANG XiaofengXIONG Feng
(The Affiliated Hospital of Southwest Jiaotong UniversityThe Third People’s Hospital of ChengduChengdu 610036SichuanChina)
关键词:
超声心动图心脏再同步化治疗优化
Keywords:
EchocardiographyCardiac resynchronization therapyOptimize
DOI:
10.16806/j.cnki.issn.1004-3934.2019.07.020
摘要:
心脏再同步化治疗是一种成熟地用于治疗心力衰竭的方法,可有效减轻患者心力衰竭症状并降低死亡率,延长生存期,但目前仍有部分患者接受心脏再同步化治疗后未获益,可能与患者筛选、电极植入、术后参数等方面有关。超声心动图技术具有无创、实时及可重复性等优点,成为协助优化心脏再同步化治疗疗效的重要工具。
Abstract:
As a mature treatment for heart failure,cardiac resynchronization therapy can release heart failure symptoms effectively,reduce the death rate and improve rate of survival. At present, there are still some patients do not benefit from cardiac resynchronization therapy,which may related to patient selection, electrode implantation, parameter optimization or other aspects. Ultrasonic cardiography,which is non-invasive and repeatable, making it an important way for the optimization of cardiac resynchronization therapy

参考文献/References:

[1].Ponikowski P,Voors AA, Anker SD, et al. 2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure[J]. Rev Esp Cardiol (Engl Ed),2016 ,69(12):1167.
[2].Jones S,Lumens J,Sohaib, SMA,et al. Cardiac resynchronization therapy: mechanisms of action and scope for further improvement in cardiac function[J]. Europace,2017,19(7):1178-1186.
[3].Rickard J, Michtalik H, Sharma, R et.al. Predictors of response to cardiac resynchronization therapy: A systematic review[J]. Int J Cardiol,2016, 225: 345-352.
[4].Mele D, Bertini M, Malagù M,et al. Current role of echocardiography in cardiac resynchronization therapy[J]. Heart Fail Rev,2017,22(6):699-722.
[5].Rickard J, Baranowski B,Wilson Tang WH, et.al. Echocardiographic predictors of long-term survival in patients undergoing cardiac resynchronization therapy: what is the optimal metric[J]. J Cardiovasc Electrophysiol,2017,28(4):410-415.
[6].Ciampi Q,Carpeggiani C,Michelassi C,et al. Left ventricular contractile reserve by stress echocardiography as a predictor of response to cardiac resynchronization therapy in heart failure: a systematic review and meta-analysis[J]. BMC Cardiovasc Disord,2017,17(1):223.
[7].Verbrugge FH, Verhaert D, Grieten L,et al.Revisiting diastolic filling time as mechanistic insight for response to cardiac resynchronization therapy[J]. Europace, 2013,15(12):1747-1756.
[8].Mele D, Agricola E, Monte AD, et al.Pacing transmural scar tissue reduces left ventricle reverse remodeling after cardiac resynchronization therapy[J]. Int J Cardiol,2013,167(1):94-101.
[9].Mele D,Luisi GA,Malag M,et al. Echocardiographic evaluation of cardiac dyssynchrony: Does it still matter[J]. Echocardiography,2018 ,35(5):707-715.
[10].Sassone B, Capecchi A, Boggian G, et al. Value of baseline left lateral wall postsystolic displacement assessed by M-mode to predict reverse remodeling by cardiac resynchronization therapy[J]. Am JCardiol,2007,100(3):470-475.
[11].Sinner GJ, Gupta VA, Seratnahaei A, et al. Atrioventricular dyssynchrony from empiric device settings is common in cardiac resynchronization therapy and adversely impacts left ventricular morphology and function[J]. Echocardiography,2017,34(4):496-503.
[12].Kuznetsov VA,Soldatova AM,Kasprzak JD,et al. Echocardiographic markers of dyssynchrony as predictors of super-response to cardiac resynchronisation therapy - a pilot study[J]. Cardiovasc Ultrasound,2018,16(1):24.
[13].Tanaka H, Nesser HJ, Buck T, et al. Dyssynchrony by speckle-tracking echocardiography and response to cardiac resynchronization therapy: results of the Speckle Tracking and Resynchronization (STAR) study[J]. Eur Heart J,2010,31(14):1690-1700.
[14].Fulati Z,Liu Y,Sun N, et al. Speckle tracking echocardiography analyses of myocardial contraction efficiency predict response for cardiac resynchronization therapy[J]. Cardiovasc Ultrasound,2018,16(1):30.
[15].Delgado-Montero A, Tayal B, Goda A, et al. Additive prognostic value of echocardiographic global longitudinal and global circumferential strain to electrocardiographic criteria in patients with heart failure undergoing cardiac resynchronization therapy[J]. Circ Cardiovasc Imaging,2016,9(6).pii: e004241.
[16].Seo Y, Ishizu T,Machino-Ohtsuka T,et al. Incremental value of speckle tracking echocardiography to predict cardiac resynchronization therapy (CRT) Responders[J]. J Am Heart Assoc,2016,5(10).?pii: e003882.
[17].Khidir MJH,Abou R,Yilmaz, D,et al. Prognostic value of global longitudinal strain in heart failure patients treated with cardiac resynchronization therapy[J]. Heart Rhythm,2018 ,15(10):1533-1539.
[18].Cai Q,Ahmad M. Left ventricular dyssynchrony by three-dimensional echocardiography: current understanding and potential future clinical applications[J]. Echocardiography,2015,32(8):1299-1306.
[19].H?ke U,Bax JJ, DelgadoV,et al. Assessment of left ventricular dyssynchrony by three-dimensional echocardiography: Prognostic value in patients undergoing cardiac resynchronization therapy[J]. J Cardiovasc Electrophysiol, 2018,29(5):780-787.
[20].Gorcsan J,Tayal B.Newer echocardiographic techniques in cardiac resynchronization therapy[J]. Heart Fail Clin,2017,13(1):53-62.
[21].Liang Y, Yu H, Zhou W,et al. Left ventricular lead placement targeted at the latest activated site guided by electrophysiological mapping in coronary sinus branches improves response to cardiac resynchronization therapy[J]. J Cardiovasc Electrophysiol,2015,26(12):1333-1339.
[22].Khan FZ, Virdee MS, Palmer CR, et al. Targeted left ventricular lead placement to guide cardiac resynchronization therapy: the TARGET study: a randomized,controlled trial[J]. J Am Coll Cardiol,2012,59(17):1509-1518.
[23].Bakos Z, Markstad H,Ostenfeld E,et al. Combined preoperative information using a bullseye plot fromspeckle tracking echocardiography, cardiac CT scan, and MRI scan: targeted leftventricular lead implantation in patients receiving cardiac resynchronization therapy[J]. Eur Heart J Cardiovasc Imaging, 2014, 15(5):523-531.
[24].Cobb DB, Gold MR.The role of atrioventricular and interventricular optimization for cardiac resynchronization therapy[J].Heart Failure Clin,2017,13(1):209-223.
[25].Urbanek B,Kaczmarek K,Klimczak A,et al. Potential benefit of optimizing atrioventricular & interventricular delays in patients with cardiac resynchronization therapy[J]. Indian J Med Res,2017,146(1):71-77 .
[26].Tolosana JM,Brugada J. Optimizing cardiac resynchronization therapy devices in follow-up to improve response rates and outcomes[J]. Card Electrophysiol Clin,2019,11(1):89-98.
[27].Rowe MK,Kaye GC. Advances in atrioventricular and interventricular optimization of cardiac resynchronization therapy - what’s the gold standard?[J]. Expert Rev Cardiovasc Ther,2018,16(3):183-196.
[28].Spartalis M,Tzatzaki E,Spartalis E, et al . The role of echocardiography in the optimization of cardiac eesynchronization therapy: current evidence and future perspectives[J]. Open Cardiovasc Med J,2017,11:133-145.

相似文献/References:

[1]郭彩艳 靳春荣.腺苷药物在心血管疾病诊治中的应用进展[J].心血管病学进展,2019,(7):1011.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.012]
 GUO CaiyanJIN Chunrong.Progress in the Application of Adenosine Drugs in the Diagnosis and Treatment of Cardiovascular Diseases[J].Advances in Cardiovascular Diseases,2019,(7):1011.[doi:10.16806/j.cnki.issn.1004-3934.2019.07.012]
[2]陈丽娜 练春燕 刘慧.超声心动图评估右心室功能的临床应用价值[J].心血管病学进展,2020,(3):223.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.002]
 CHEN Lina,LIAN Chunyan,LIU Hui.Clinical Application Value of Echocardiography in Evaluating Right Ventricular Function[J].Advances in Cardiovascular Diseases,2020,(7):223.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.002]
[3]胡威,苏芳菊,张卫泽.左室四极导线在心脏再同步化治疗中的应用进展[J].心血管病学进展,2020,(3):268.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.013]
 HU Wei,SU Fangju,ZHANG Weize.Application of Left Ventricular Quadrupole in Cardiac Resynchronization Therapy[J].Advances in Cardiovascular Diseases,2020,(7):268.[doi:10.16806/j.cnki.issn.1004-3934.2020.03.013]
[4]熊倩 俞杉.心肌应变成像在CRT评估中的研究进展[J].心血管病学进展,2020,(4):399.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.018]
 XIONG QianYU Shan.Myocardial Strain Imaging in C Assessment[J].Advances in Cardiovascular Diseases,2020,(7):399.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.018]
[5]徐敏,任卫东,熊峰,等.实时三维超声牛眼图定量评价正常新生儿左心室收缩同步性[J].心血管病学进展,2020,(4):434.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.025]
 XU MinREN WeidongXIONG FengWANG ShuzhenZHANG LijuanHUANG XiaofengLIU ChunxiaLEI Yali.Quantitative Assessment of the Left Ventricular Systolic Synchronicity in Normal Newborns Using Illustration of the Bull Eye with Real-time Three-dimensional Echocardiography[J].Advances in Cardiovascular Diseases,2020,(7):434.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.025]
[6]林杰 李海瑞 李海鹰.左束支区域起搏的现状和展望[J].心血管病学进展,2020,(5):462.[doi:10.16806/j.cnki.issn.1004-3934.2020.05.006]
 LIN Jie,LI Hairui,LI Haiying.Present and Future of Left Bundle Branch Area Pacing[J].Advances in Cardiovascular Diseases,2020,(7):462.[doi:10.16806/j.cnki.issn.1004-3934.2020.05.006]
[7]韩培天 魏晓岩 杜彬彬 张津宁 王文州 郭艳娇 张克成 李春彦 李文慧.心肌缺血时间对STEMI患者急诊PCI术后早期左室舒张功能的影响及相关因素分析[J].心血管病学进展,2020,(6):660.[doi:10.16806/j.cnki.issn.1004-3934.2020.06.024]
 HAN Pei-tian,WEI Xiaoyan,DU Binbin,et al.Effect of Myocardial Ischemia Duration on Early Left Ventricular Diastolic Function in STEMI Patients After Emergency PCI and Analysis of Related Factors[J].Advances in Cardiovascular Diseases,2020,(7):660.[doi:10.16806/j.cnki.issn.1004-3934.2020.06.024]
[8]刘静 彭礼清.心外膜脂肪组织定量评价的影像学进展[J].心血管病学进展,2020,(9):922.[doi:10.16806/j.cnki.issn.1004-3934.2020.09.009]
 LIU Jing,PENG Liqing.Quantitative Evaluation of Epicardial Adipose Tissue Measured by Different Imaging Methods[J].Advances in Cardiovascular Diseases,2020,(7):922.[doi:10.16806/j.cnki.issn.1004-3934.2020.09.009]
[9]陈天欢 李小明.心力衰竭患者心脏再同步化治疗最新进展[J].心血管病学进展,2020,(12):1290.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.016]
 CHEN Tianhuan,LI Xiaoming.Cardiac Resynchronization Therapy in Patients with Heart Failure[J].Advances in Cardiovascular Diseases,2020,(7):1290.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.016]
[10]沈文茜 杜国庆.机器学习在超声心动图中的应用进展[J].心血管病学进展,2021,(1):43.[doi:10.16806/j.cnki.issn.1004-3934.2021.01.000]
 SHEN Wenqian,DU Guoqing.Machine Learning in Echocardiography[J].Advances in Cardiovascular Diseases,2021,(7):43.[doi:10.16806/j.cnki.issn.1004-3934.2021.01.000]

更新日期/Last Update: 2019-12-17